RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE

被引：0
|
作者：
Pleyer, C. [1 ]
Sidana, S. [1 ]
Erik, O. [2 ]
Radivoyevitch, T. [3 ]
Advani, A. S. [4 ]
Gerds, A. T. [4 ]
Carraway, H. [4 ]
Kalaycio, M. [4 ]
Maciejewski, J. P. [4 ]
Sekeres, M. A. [4 ]
Mukherjee, S. [4 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30080-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
79
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [31] An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer
    Sawka, Anna M.
    Brierley, James D.
    Tsang, Richard W.
    Thabane, Lehana
    Rotstein, Lorne
    Gafni, Amiram
    Straus, Sharon
    Goldstein, David P.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (02) : 457 - +
  • [32] Risk factors for well-differentiated thyroid cancer in men
    Zivaljevic, Vladan
    Slijepcevic, Nikola
    Sipetic, Sandra
    Paunovic, Ivan
    Diklic, Aleksandar
    Zoric, Goran
    Kalezic, Nevena
    TUMORI JOURNAL, 2013, 99 (04): : 458 - 462
  • [33] The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non-Well-Differentiated, and Anaplastic Thyroid Cancers
    Pannone, Giuseppe
    Santoro, Angela
    Pasquali, Daniela
    Zamparese, Rosanna
    Mattoni, Marilena
    Russo, Giuseppe
    Landriscina, Matteo
    Piscazzi, Annamaria
    Toti, Paolo
    Cignarelli, Mauro
    Lo Muzio, Lorenzo
    Bufo, Pantaleo
    THYROID, 2014, 24 (03) : 511 - 519
  • [34] Well-differentiated carcinoma of the thyroid
    Boone, RT
    Fan, CY
    Hanna, EY
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 73 - +
  • [35] Well-differentiated thyroid carcinoma
    Segal, K
    Raveh, E
    Lubin, E
    Abraham, A
    Shvero, J
    Feinmesser, R
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1996, 17 (06) : 401 - 406
  • [36] Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment
    Acibucu, F.
    Acibucu, D. O.
    Akkar, O. B.
    Dokmetas, H. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (10) : 593 - 596
  • [37] Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma
    Sawka, Anna M.
    Orlov, Steven
    Gelberg, Jacob
    Stork, Barry
    Dowar, Mark
    Shaytzag, Michael
    Tabatabale, Vafa
    Freeman, Jeremy L.
    Walfish, Paul G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (06): : 693 - 700
  • [38] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Iain J. Nixon
    Frank L. Palmer
    Monica M. Whitcher
    Ashok R. Shaha
    Jatin P. Shah
    Snehal G. Patel
    Ian Ganly
    Annals of Surgical Oncology, 2011, 18 : 767 - 770
  • [39] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Nixon, Iain J.
    Palmer, Frank L.
    Whitcher, Monica M.
    R. Shaha, Ashok
    Shah, Jatin P.
    Patel, Snehal G.
    Ganly, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 767 - 770
  • [40] Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
    Toro-Tobon, David
    Morris, John C.
    Hilger, Crystal
    Peskey, Candy
    Durski, Jolanta M.
    Ryder, Mabel
    THYROID, 2024, 34 (01) : 70 - 81
12345